Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 60 recruiting studies, sorted by proximity — each links to its official registry page
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms
Phase 2
Interventional 308 participants sought
Southern Urology, LLC ( Site 0145) — Lafayette, Louisiana (1.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: NRG Oncology
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: DalCor Pharmaceuticals
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 750 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Peripheral Vascular Diseases
N/A
Observational 5,000 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Boston Scientific Corporation
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: NRG Oncology
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 2
Interventional 131 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Protara Therapeutics
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Southern Urology (Urology America) — Lafayette, Louisiana (1.3 mi)
· Sponsor: CG Oncology, Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Heart Failure
N/A
Observational 500 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Cordio Medical
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Prostatic Neoplasms
Phase 2
Interventional 100 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 200 participants sought
Combined Gastro LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Takeda
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Benign Prostatic Hyperplasia
N/A
Interventional 215 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Rivermark Medical
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pacific Edge Limited
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Moderate-to-Severe Atopic Dermatitis
Phase 3
Interventional 510 participants sought
Nektar Investigative Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Nektar Therapeutics
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: NRG Oncology
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 980 participants sought
Care Access - New Iberia-Site Number: 8400031 — New Iberia, Louisiana (19.1 mi)
· Sponsor: Sanofi